Recordati Acquires Rights to Enjaymo from Sanofi for $825 Million

Duckhorn Acquired by Butterfly Equity at $1.95 Billion

Eliem Therapeutics Changes Name to Climb Bio

John McEntee’s @daterightstuff TikTok Provides A Window Into The Future of Political Communications, Business Development

Aktis Oncology Unveils $175M Series B Financing to Advance Proprietary Radio Pharma

Vivani Medical to Test Implant in Obese and Overweight Patients

Combatting Fake News with ID Verification: Notified COO Erik Carlson at Nasdaq